drugset / Trial / NCT01925144
A Study of Baricitinib and Omeprazole in Healthy Participants
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The main purpose of this study is to find out how the body will react to a study drug called baricitinib when taken with another drug called omeprazole. For each participant, this study will include 2 periods in fixed order. The study will last approximately 25 days, not including screening.
Timeline
- Start
- 2013-10
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baricitinib | Small molecule | 10 mg | Oral |
| Subject | Omeprazole | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.